Emil Kuriakose Terns Pharmaceuticals, Inc. (TERN) insider trading activity

TERN Quotes by TradingView

Emil Kuriakose is Chief Medical Officer of Terns Pharmaceuticals, Inc.. Currently has a direct ownership of 51,520 shares of TERN, which is worth approximately $1.16 Million. The most recent transaction as insider was on Oct 01, 2025, when has been sold 944 shares (Common Stock) at a price of $7.85 per share, resulting in proceeds of $7,410. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 51.5K
1.8% 3M change
n/a 12M change
Total Value Held $1.16 Million

Emil Kuriakose Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 01 2025
SELL
Open market or private sale
$7,410 $7.85 p/Share
944 Reduced 1.8%
51,520 Common Stock
Jul 01 2025
SELL
Open market or private sale
$3,642 $4.27 p/Share
853 Reduced 1.6%
52,464 Common Stock
Apr 01 2025
SELL
Open market or private sale
$2,370 $2.49 p/Share
952 Reduced 1.75%
53,317 Common Stock
Jan 02 2025
SELL
Open market or private sale
$25,586 $5.71 p/Share
4,481 Reduced 7.63%
54,269 Common Stock

Also insider at

CALA
Calithera Biosciences, Inc. Healthcare
CHIEF MEDICAL OFFICER
EK

Emil Kuriakose

Chief Medical Officer
South San Francisco, CA

Track Institutional and Insider Activities on TERN

Follow Terns Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TERN shares.

Notify only if

Insider Trading

Get notified when an Terns Pharmaceuticals, Inc. insider buys or sells TERN shares.

Notify only if

News

Receive news related to Terns Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TERN